Home › NDC Lookup › RxCUI directory › RxCUI 1046610

Naphazoline hydrochloride 0.5 MG/ML Nasal Spray — RxCUI 1046610

RxNorm drug concept · Semantic clinical drug
RxCUI 1046610 Semantic clinical drug · SCD ● Current RxNorm concept 5 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1046610
Official nameNaphazoline hydrochloride 0.5 MG/ML Nasal Spray
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asnaphazoline HCl 0.05 % Nasal Spray
FDA products mapped5
Package NDCs mapped5
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Naphazoline hydrochloride 0.5 MG/ML Nasal Spray Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Naphazoline hydrochloride 0.5 MG/ML Nasal Spray RxCUI 1046610

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Naphazoline 7247
    • Naphazoline hydrochloride 82054
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Privine 225201
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Naphazoline Nasal Spray 374561
    • Naphazoline hydrochloride Nasal Spray 2648797
    • Naphazoline Inhalant Product 1156999
    • Naphazoline Nasal Product 1157000
    • Naphazoline hydrochloride Inhalant Product 2660389
    • Naphazoline hydrochloride Nasal Product 2659746
    • Naphazoline Nasal Spray [Privine] 361969
    • Naphazoline hydrochloride Nasal Spray [Privine] 2654980
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Naphazoline hydrochloride 0.5 MG/ML 1043597
    • Naphazoline hydrochloride 0.5 MG/ML Nasal Spray [Privine] 1046611
    • Naphazoline hydrochloride 0.5 MG/ML [Privine] 1046603

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Naphazoline hydrochloride 0.5 MG/ML SCDC · 1043597
  • Naphazoline Nasal Spray SCDF · 374561
  • Naphazoline hydrochloride Nasal Spray SCDFP · 2648797
  • Naphazoline Inhalant Product SCDG · 1156999
  • Naphazoline Nasal Product SCDG · 1157000
  • Naphazoline hydrochloride Inhalant Product SCDGP · 2660389
  • Naphazoline hydrochloride Nasal Product SCDGP · 2659746

Brand-Name Concepts

  • Naphazoline hydrochloride 0.5 MG/ML Nasal Spray [Privine] SBD · 1046611
  • Naphazoline hydrochloride 0.5 MG/ML [Privine] SBDC · 1046603
  • Naphazoline Nasal Spray [Privine] SBDF · 361969
  • Naphazoline hydrochloride Nasal Spray [Privine] SBDFP · 2654980
  • Privine Inhalant Product SBDG · 1178923
  • Privine Nasal Product SBDG · 1178924
  • Privine BN · 225201

📦 FDA Products & Package NDCs

5 products · 5 package NDCs
5 package NDCs map to RxCUI 1046610 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
85248-0053-01 30 mL in 1 BOTTLE (85248-053-01) SKAPEMED ORIGINAL NASAL Jiangxi Yudexi Pharmaceutical Co., LTD 2026-02-06
85248-0083-01 30 mL in 1 BOTTLE (85248-083-01) NATUHEAL ORIGINAL NASAL Jiangxi Yudexi Pharmaceutical Co., LTD 2026-02-08
85248-0099-01 30 mL in 1 BOTTLE (85248-099-01) SERYNTH FAST RELIEF NASAL Jiangxi Yudexi Pharmaceutical Co., LTD 2026-02-08
85248-0111-01 30 mL in 1 BOTTLE (85248-111-01) DERMFREE ORIGINAL NASAL Jiangxi Yudexi Pharmaceutical Co., LTD 2026-02-08
85248-0112-01 30 mL in 1 BOTTLE (85248-112-01) DERMFREE ORIGINAL NASAL Jiangxi Yudexi Pharmaceutical Co., LTD 2026-02-08
Observed labelers: Jiangxi Yudexi Pharmaceutical Co., LTD (5) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.